Revlimid lenalidomide regulatory update

Japan's Ministry of Health, Labor and Welfare granted Orphan Drug designation for Revlimid lenalidomide to treat anemia due to low- or intermediate-risk myelodysplastic syndromes (MDS) with 5q chromos...